- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Psoriatic arthritis
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 302KB)
Apremilast – March 2023
Apremilast: Tablet 30 mg, Pack containing 4 tablets of 10 mg, 4 tablets of 20 mg, 19 tablets of 30 mg; Otezla®
Last updated
30 June 2023